What are the opening hours?

Monday 9am - 5pm Tuesday 9am - 5pm Wednesday 9am - 5pm Thursday 9am - 5pm Friday 9am - 5pm

Journal of the Advanced Practitioner in Oncology

Home
United States
Huntington, NY
Journal of the Advanced Practitioner in Oncology

We are the first peer-reviewed journal developed for advanced practitioners in oncology.

The Journal of the Advanced Practitioner in Oncology (JADPRO) is a peer-reviewed publication published 8 times a year.

01/30/2026

What should APs know about the newest therapy for cTTP?
Learn about the mechanism of action, clinical trial results, and real-world considerations for recombinant ADAMTS13, the first FDA-approved therapy specifically for congenital thrombotic thrombocytopenic purpura: https://bit.ly/4sZc4n4

01/29/2026

Let the countdown begin! Open your calendar and block these dates for JADPRO Live 2026: October 15-18. We want you to see you there!
Stay connected to JADPROLive.com for more info. Registration opens in the Spring!

01/27/2026

In oncology, complex cases rarely have simple answers.
In "Two Heads Are Better Than One," Editor-in-Chief Beth Faiman highlights how second opinions and interdisciplinary collaboration strengthen clinical decision-making and improve patient outcomes.
Read the article: https://bit.ly/3NyvWNC

01/22/2026

Unexpected neutropenia can change the course of cancer care.
For some patients, benign ethnic neutropenia (BEN)—also known as Duffy-null associated neutrophil count (DANC)—can significantly impact oncology treatment decisions if unrecognized.
A new proposed algorithm helps advanced practitioners identify BEN/DANC early, reducing unnecessary delays, dose reductions, and treatment interruptions.

Learn more: https://jadpro.com/online-first/2026/can-a-benign-hematology-phenomenon-critically-impact-the-neutropenia-status-and-treatment-of-patients-with-cancer/

01/20/2026

The January/February issue of the Journal of the Advanced Practitioner in Oncology is LIVE!
Discover ways improve the quality of care for patients with cancer, support critical issues in advanced practice in oncology and recognize the expanding contributions of advanced practitioners in oncology.

Highlights of this issue include:
- Use of Remote Monitoring in Care Management for Bone Marrow Transplant Patients
- Melatonin for the Management of Cancer-Related Fatigue in Breast Cancer
- Integrative Oncology Models of Care
- The first FDA-approved product for the management of congenital thrombotic thrombocytopenic purpura
And more!

Read the issue: https://jadpro.com/issues/volume-17-number-1-janfeb-2026/

01/19/2026

The Unmet Need in 1L HR+/HER2– Advanced Breast Cancer

Learn more: https://bit.ly/4r7y6SS

©2025 AstraZeneca. All rights reserved.
US-106021 Last Updated 10/25

01/16/2026

Substance use disorders (SUDs) among women with gynecologic cancers pose challenges to treatment adherence and well-being, however, routine screening practices have not been widely adopted.
The project demonstrated that routine substance use disorder screening in gynecologic oncology is both feasible and effective, highlighting the importance of integrating structured screening into practice while addressing patient education and communication needs.
Read the full research article: https://bit.ly/3YRtu6W

01/14/2026

Rethinking ESR1 Testing in HR+/HER2– Advanced Breast Cancer

Learn more: https://bit.ly/3ZcWjel

©2025 AstraZeneca. All rights reserved.
US-106020 Last Updated 10/25

01/07/2026

Pain is one of the most distressing symptoms for patients diagnosed with cancer.
In this article, Editor-in-Chief Beth Faiman discusses her approach to pain management, including determining the type and underlying source of pain while balancing the risks of opioid misuse with the benefits of pain control.
Learn more: https://bit.ly/3Yivmpl

01/02/2026

A recent quality improvement initiative focused on enhancing the appropriate prescribing of olanzapine for chemotherapy-induced nausea and vomiting (CINV) in an outpatient oncology setting.
The project aimed to increase compliance with evidence-based prescribing for adult patients receiving highly emetogenic chemotherapy, helping ensure patients receive optimal supportive care alongside their cancer treatment.
Read the article: https://bit.ly/3MK2tzF

12/30/2025

Review a clinically relevant appraisal of optimized dosing of regorafenib in patients with metastatic colorectal cancer and the implications for patient management from the perspective of oncologists, advanced practice providers, and pharmacists.
Read the article: https://bit.ly/3MK2tzF

12/26/2025

Discover coagulation treatment optimization and recommendations with the Factor Approach.
Learn more about the steps and considerations involved for the development of a blood factor product formulary : https://bit.ly/4pkGddv

Address

94 N Woodhull Road
Huntington, NY
11743

Opening Hours

Monday	9am - 5pm
Tuesday	9am - 5pm
Wednesday	9am - 5pm
Thursday	9am - 5pm
Friday	9am - 5pm

Website

http://www.advancedpractitioner.com/

Alerts

Be the first to know and let us send you an email when Journal of the Advanced Practitioner in Oncology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.